Clinical Trials Browser

Phase 2 × Withdrawn × loncastuximab tesirine × Clear all

NCT05222438 2023-11-01

Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant

Phase 2 Withdrawn

Lymphoma, Large B-Cell, Diffuse